Drugs / Cyclo-His Pro
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00878605 | Apr 2010 → Jun 2013 | type 2 diabetes mellitus | VA Office of Research and Development | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cyclo-His Pro | “a Cyclo-Z capsule containing Cyclo-His Pro (CHP) 0 (placebo), 3 mg (minimally effective), 9 mg (optimally effective), or 15 mg (no-additional effect) plus 20 mg zinc on...” NCT00878605 ↗1“a cyclic dipeptide Cyclo (his-pro) plus zinc (Cyclo-Z) treatment improved clinical conditions of diabetes in various animal models and a phase 1 clinical trial.” NCT00878605 ↗ |
| Modality | Peptide | “a cyclic dipeptide Cyclo (his-pro)” NCT00878605 ↗ |